Cici Liu, MD
Gynecologic Oncology · Rochester, NYNPI 1952620577
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Intuitive Surgical at 53.2% of the total. 2025 is the largest year on record at $4,551, more than ten times the $102 reported in 2019.
Across 75 payments — averaging $97.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Medical Device Business Services, Inc.$1K
- AstraZeneca$442
- Myriad Genetic Laboratories, Inc.$206
- Conmed Corporation$168
- Johnson & Johnson$166
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,93926%
- Food & beverage$2,89339%
- Education$2,50034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $3,903 |
| Medical Device Business Services, Inc. | 6 | $1,332 |
| AstraZeneca | 10 | $442 |
| Myriad Genetic Laboratories, Inc. | 5 | $206 |
| Conmed Corporation | 3 | $168 |
| Johnson & Johnson | 4 | $166 |
| Eisai Inc. | 5 | $150 |
| Dilon Technologies, Inc. | 1 | $148 |
| Genentech USA, Inc. | 1 | $102 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| Smith+Nephew | 2 | $96 |
| Bluewind Medical | 3 | $82 |
| Astellas Pharma US Inc | 3 | $64 |
| Baxter Healthcare | 2 | $59 |
| Merck | 2 | $45 |
| Biotissue Holdings Inc. | 2 | $41 |
| Minerva Surgical, Inc | 1 | $36 |
| Hologic Sales And Service, LLC | 1 | $35 |
| AbbVie | 1 | $32 |
| Coloplast | 2 | $29 |
| Medtronic | 1 | $23 |
| Seagen Inc. | 1 | $23 |
| Tempus AI, Inc | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$2,500
- Enseal$1,283
- Da Vinci Surgical System$1,250
- HemoBlast Bellows$148
- LYNPARZA$121
- PreciseTumor$111
- Avastin$102
- AIRSEAL$100
How this compares
$7,332 in reported general payments places this provider in the 80th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $2,127 |
| Clobetasol Propionate | 12 | $565 |
| Celecoxib | 32 | $543 |
| Nystatin | 14 | $248 |
| Imiquimod | 13 | $174 |
| Oxycodone Hcl | 27 | $154 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Rochester
- Richard MooreRochester$124K
- Ashlee SmithRochester$2K
- Heidi GodoyAlbany$1.1M
- Bhavana PothuriNew York$366K
- Joyce BarlinAlbany$208K
- Wiley BunnSyracuse$201K
- Ghadir SalameBrooklyn$179K
- Mario LeitaoNew York$116K
- Konstantin ZakashanskyNew York$93K
- Evelyn CantilloNew York$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.